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Abstract
Measurement of lung function can be difficult in young children. Structured
light plethysmography (SLP) is a novel, noncontact method of measuring tidal
breathing that monitors displacement of the thoraco–abdominal wall. SLP was
used to compare breathing in children recovering from an acute exacerbation
of asthma/wheeze and an age-matched cohort of controls. Children aged
2–12 years with acute asthma/wheeze (n = 39) underwent two 5-min SLP
assessments, one before bronchodilator treatment and one after. SLP was per-
formed once in controls (n = 54). Nonparametric comparisons of patients to
healthy children and of pre-bronchodilator to post-bronchodilator were made
for all children, and also stratified by age group (2–5 vs. 6–12 years old). In
the asthma/wheeze group, IE50SLP (inspiratory to expiratory flow ratio) was
higher (median 1.47 vs. 1.31; P = 0.002), thoraco–abdominal asynchrony
(TAA) and left–right asynchrony were greater (both P < 0.001), and respira-
tory rate was faster (P < 0.001) than in controls. All other timing indices were
shorter and displayed reduced variability (all P < 0.001). Variability in time to
peak inspiratory flow was also reduced (P < 0.001). Younger children showed
a greater effect than older children for TAA (interaction P < 0.05). After
bronchodilator treatment, the overall cohort showed a reduction in within-
subject variability in time to peak expiratory flow only (P < 0.001). Younger
children exhibited a reduction in relative contribution of the thorax, TAA,
and variability in TAA (interaction P < 0.05). SLP can be successfully per-
formed in young children. The potential of SLP to monitor diseases such as
asthma in children is worthy of further investigation. ClinicalTrials.gov identi-
fier: NCT02543333.
Introduction
Effective management of asthma and other respiratory
conditions relies on accurate assessment of lung function
(Beydon et al. 2007; van den Wijngaart et al. 2015).
Although spirometry is the gold standard (Global Initia-
tive for Chronic Obstructive Lung Disease, 2010), it is
often not suitable for young children who may be unable
or unwilling to perform forced breathing maneuvers (van
den Wijngaart et al. 2015). An alternative strategy could
be to measure breathing patterns at rest (i.e., “tidal breath-
ing”). Existing methods for assessing tidal breathing
include pneumotachography (PNT) and respiratory induc-
tive plethysmography (RIP). Both techniques can be used
in young children (Stick et al. 1992; Bates et al. 2000), but
practical drawbacks have limited their use clinically.
Specifically, the use of a mouthpiece or mask in PNT may
cause individuals to alter their normal breathing pattern,
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while slippage of the transducer bands used in RIP can
affect the accuracy of data (Weissman et al. 1984; Stick
et al. 1992; Caretti et al. 1994; Laveneziana et al. 2015a).
Furthermore, although some studies have reported respi-
ratory disease-related changes in certain tidal breathing
parameters, there is no agreement on which parameter(s)
should be routinely assessed (Kuratomi et al. 1985; Brack
et al. 2002; Schmalisch et al. 2005).
Structured light plethysmography (SLP) is a novel
light-based technique enabling detailed assessment of tidal
breathing patterns over consecutive breaths. Unlike PNT
and RIP, SLP is a noncontact method that does not
require the use of a mouthpiece, nose clip, or other
device. Instead, SLP measures movement (or “displace-
ment”) of the anterior thoraco–abdominal (TA) wall. SLP
is performed while the child is breathing normally and
therefore can be performed in infants and very young
children. Timing indices of tidal breathing such as respi-
ratory rate (RR), inspiratory time (tI), and expiratory
time (tE) measured by SLP have shown good agreement
with PNT (Motamedi-Fakhr et al. 2017a).
In this observational cohort study, we compared SLP-
measured tidal breathing parameters in children recover-
ing from an acute exacerbation of asthma or wheeze and
receiving bronchodilator medication with an age-matched
group of healthy controls. We also compared these effects
in younger children (aged 2–5 years), who are generally
considered to be too young to perform spirometry, with
those in older children (aged 6–12 years).
Materials and Methods
Participants
The study recruited children aged 2–12 years admitted to
hospital wards following an acute exacerbation of asthma
(or breathing difficulties/wheeze in those without a formal
asthma diagnosis) between March 2014 and June 2015.
As part of standard care, these children received regular
inhaled bronchodilators with the frequency of treatment
dependent on the severity of their condition. Children
were recruited between days 1 and 3 after admission
when they were in the recovery phase of an acute attack,
on a treatment frequency of 3-h or longer regular salbuta-
mol MDI, and, in their clinician’s opinion, were well
enough to participate. Results from the asthma cohort
were compared with those from a group of healthy chil-
dren aged 2–12 years without a diagnosis or symptoms of
asthma or other respiratory condition.
Children were excluded from the study if they had signif-
icant comorbidity or chest wall abnormality, obstructive
sleep apnea, a body mass index >40 kg/m2, any acute or
chronic condition that restricted his/her ability to
participate, or they were unable to comply with the proto-
col. The study was performed at the Royal Stoke University
Hospital (Stoke-on-Trent, UK) and Addenbrooke’s Hospi-
tal (Cambridge, UK).
Study design
Once well enough, children recovering from an acute
exacerbation of asthma/wheeze underwent two 5-min SLP
assessments. The first took place 5–10 min before admin-
istration of a bronchodilator, which was given as part of
standard treatment and at a time determined by their
clinician as necessary for their care. The number of bron-
chodilator treatments administered prior to this varied
between children according to clinical need. The second
SLP assessment occurred approximately 10–15 min after
bronchodilator administration. SLP was performed once
in the healthy children. A research nurse provided distrac-
tion during the procedure by means of a cartoon video
viewed on a tablet so that subjects remained as still as
possible.
The study (ClinicalTrials.gov identifier: NCT02543333)
was conducted in line with the International Conference
on Harmonisation Good Clinical Practice guidelines and
was approved by the UK Health Research Authority
National Research Ethics Service (reference number 11/
EE/00/37). Parents/guardians provided written informed
consent.
SLP procedure and data analysis
Tidal breathing was measured using an SLP device
(Thora-3DiTM, PneumaCare Ltd., Ely, Cambridgeshire,
UK), as previously described (Hmeidi et al. 2017). Briefly,
a grid of light was projected onto the TA wall and
changes in the grid pattern were recorded using two digi-
tal cameras in the scanner head of the SLP device
(Fig. 1). Images captured by the digital cameras were
translated into a virtual surface representing each child’s
TA wall. To ensure data were as artifact-free as possible,
it was decided prior to analysis that a dataset would be
excluded if data artifacts affected more than 50% of cap-
tured respiratory cycles. Individual breaths were detected
using a breath detection algorithm based on the works of
Bates et al. (2000) and Schmidt et al. (1998) (MATLAB,
R2015b; Mathworks, Natick, MA, USA).
Tidal breathing parameters
Methods for calculation of tidal breathing parameters
obtained from SLP have been reported in detail elsewhere
(Hmeidi et al. 2017). The categories of parameters are
described briefly below.
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Timing indices
Timing indices and ratios (RR, tI, tE, total breath time
[tTot], and tI/tE and tI/tTot) were obtained from the
average TA wall displacement versus time signal, which is
a measure analogous to volume.
Flow-based parameters
Other parameters were derived from the rate of TA wall
displacement (i.e., the first derivative of the displacement
signal). These SLP parameters are similar to certain con-
ventional tidal breathing parameters as TA wall displace-
ment rate is analogous to flow. Therefore, similar
nomenclature is used to describe SLP parameters derived
from displacement rate, with the added suffix “SLP”. These
parameters include time to reach peak tidal expiratory flow
over tE (tPTEFSLP/tE), time to reach peak tidal inspiratory
flow over tI (tPTIFSLP/tI), and IE50SLP. The latter parame-
ter was calculated by dividing SLP-derived tidal inspiratory
flow at 50% of inspiratory volume (TIF50SLP) by tidal expi-
ratory flow at 50% of expiratory volume (TEF50SLP).
Regional parameters
Further SLP parameters were derived from regional dis-
placements of the TA wall and calculated by dividing the
3D reconstruction of the TA wall into two equally sized sec-
tions. Division lines for the separation of regions were a
horizontal line at the xiphisternum (for upper and lower
comparisons) and a vertical line at the sternum (for right
to left comparisons). Relative contribution of the upper
region (thorax) to each breath (rCT) was expressed as a
percentage of the total TA movement. TA asynchrony
(TAA) was expressed as the phase difference in degrees
between the upper and lower regions. Left–right hemi-thor-
acic asynchrony (HTA) was expressed as the phase differ-
ence in degrees between the left and right hemi-thoracic
regions.
Statistical analysis
These data are the first reported using SLP in young chil-
dren. Therefore, it was not possible to perform a priori
power calculations.
SLP measures multiple sequential breaths per assess-
ment. For each assessment, the median and interquartile
range (IQR) of each tidal breathing parameter were calcu-
lated. These values are presented in the results with the
prefix “m” to denote median and “v” to denote IQR (i.e.,
the within-subject variability). Individual data for each
parameter and its variability were then combined for each
cohort and summarized by their median and IQR.
A Mann–Whitney U test was used to compare each
“m” and “v” parameter in healthy children and those
with acute asthma/wheeze (both before and after bron-
chodilator administration). A robust two-way ANOVA
(raov in the R package Rfit) was used to test for signifi-
cant interactions between these effects and age (Kloke and
McKean 2012). A paired Wilcoxon signed-rank (WSR)
test was used to assess the effect of bronchodilator in chil-
dren with asthma/wheeze. A Mann–Whitney U test of the
differences (post – pre-bronchodilator) was used to com-
pare these effects in younger and older children. The abil-
ity of SLP parameters to differentiate children with
asthma from those without, and also to detect a response
to bronchodilator, was further assessed by calculating the
common language effect size (CLES) for all parameters
that demonstrated a significant difference between groups.
As this was an exploratory study, no adjustments were
made to P-values for the multiple tests conducted.
Results
Thirty-nine children with acute asthma/wheeze (26 with a
formal diagnosis of asthma) plus 54 age-matched healthy
controls were eligible for this study and provided evalu-
able data for analysis using the strict criteria outlined
above. The age distribution and demographics of the two
cohorts included in the analysis were similar (Fig. 2;
Table 1). The success rate for the SLP procedure (defined
as the number of measurements providing evaluable data
Figure 1. Principles of structured light plethysmography. A grid of
light is projected onto the thoraco–abdominal (TA) wall of a
participant. The changes in the grid pattern that occur during
breathing are recorded by two cameras, which are located in the
scanning head. These changes are translated into a virtual surface
that corresponds to the shape of the subject’s TA wall. Tidal
breathing timing indices are then calculated using the one-
dimensional movement over time trace generated from the average
axial displacement of the grid. The subject in the photo was a
volunteer and not a study participant.
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divided by the total number of measurements performed)
was 87.8% (137/156). When assessed according to age,
the success rate in older participants (aged 6–12 years
inclusive) was 93.7% (59/63) and in the younger
preschool participants (aged 2–5 years inclusive) was
83.9% (78/93). The reason for exclusion of data was poor
quality in one or both (in the case of the acute asthma
group) of the datasets, caused by interference from move-
ment, light, or creases in the t-shirt.
Several parameters differed significantly between chil-
dren recovering from an acute exacerbation of asthma/
wheeze (before bronchodilator administration) and healthy
controls (Table 2). Of the timing parameters, mRR was sig-
nificantly higher in children with asthma (30 vs. 23 brpm;
P < 0.001), while mtI (0.83 vs. 1.13 sec), mtE (1.14 vs.
1.48 sec), and mtTot (2.00 vs. 2.60 sec) were lower (all
P < 0.001). With the exception of vRR, within-subject vari-
ability in all timing indices and ratios were significantly
lower in children with asthma/wheeze than in healthy
controls. Of the flow-based parameters, mIE50SLP was sig-
nificantly higher (1.47 vs. 1.31, P = 0.002), while the
within-subject variability in tPTIFSLP/tI was significantly
lower in children with asthma/wheeze compared with
healthy children (0.16 vs. 0.21, P < 0.001; Fig. 3). Both
asynchrony parameters (mTAA and mHTA) were signifi-
cantly higher in children with asthma/wheeze (mTAA:
40.16 vs. 11.88°; mHTA: 5.53 vs. 3.43°; both P < 0.001;
Fig. 4), as were the variability in both these parameters
(vTAA: 24.08 vs. 13.53°; vHTA, 6.82 vs. 4.58°; both
P < 0.001; Fig. 4). The effects of asthma/wheeze on
younger children (aged 2–5 years) differed from those on
older children (aged 6–12 years) for mTAA only (interac-
tion P < 0.001; Table 2). For healthy children, mTAA
decreased slightly with age (12.6 and 11.4° for younger and
older children, respectively), but for children with asthma/
wheeze, mTAA decreased by more than 50% from 52.2° in
the younger cohort to 25.1° in the older cohort (Fig. 5).
No median parameter changed significantly after bron-
chodilator administration for the overall asthma/wheeze
cohort (Table 3). The only change observed was the
within-subject variability in tPTEFSLP/tE, which decreased
from 0.21 to 0.15 (P < 0.001; Fig. 3). When assessed
according to age, the older and younger cohorts differed
in the effects of bronchodilator administration for mrCT,
mTAA, and vTAA (interaction P < 0.05). Median rCT
decreased significantly in the younger cohort after bron-
chodilator administration (interaction P < 0.05 and WSR
P < 0.05), but did not change significantly in older chil-
dren and in fact increased for most individuals in this
cohort (Fig. 6). The effects of bronchodilator administra-
tion on mTAA were also significantly different in the two
cohorts, with asynchrony decreasing in younger children
but increasing in the older cohort, although the effects
were not significantly different from zero in either age
group (Fig. 6). Similarly, vTAA significantly decreased in
the younger cohort following bronchodilator treatment
(P < 0.05), but did not change in the older cohort
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Figure 2. Age distribution of the participants in the (A) healthy
and (B) acute asthma/wheeze groups.
Table 1. Participant demographics.
Healthy children
(N = 54)
Children with
acute asthma/wheeze
(N = 39)
Gender (male:
female), n
33:21 26:13
Age, years 6.1 (2.9) 5.2 (2.7)
Age groups
(2–5: 6–12 years), n
26:28 24:15
Height, cm 116.5 (21.0) 114.1 (18.3)
Data are mean (standard deviation) unless otherwise indicated.
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(Fig. 6). All parameters that were significantly different
between healthy children and those with asthma/wheeze
before administration of the bronchodilator remained so
after (Table 4).
According to CLES evaluation, mtI and mTAA demon-
strated the largest effect in distinguishing healthy children
from those with acute asthma (Table 5). These
parameters also showed the largest effect size in distin-
guishing the acute asthma group from normal after bron-
chodilator administration (mtI: 83.4%; mTAA: 81.8%), in
addition to mRR and mtTot (both 80.2%). Furthermore,
in children with asthma, within-subject variability in
tPTEFSLP/tE could detect bronchodilator effects in 74.4%
of cases (Table 5).
Table 2. SLP-assessed tidal breathing parameters in children with acute asthma/wheeze (before bronchodilator administration) versus healthy
children. Significantly different parameters are shown in bold italics.
Healthy children
(N = 54)
Children with acute
asthma/wheeze (before
bronchodilator) (N = 39)
Overall significance
(MWU test)
Age group
interaction significancea
(robust ANOVA)
Median IQR Median IQR z-statistic P-value P-value
Timing indices and ratios
mRR (brpm) 23.00 20.00–25.35 30.00 24.87–32.58 4.74 <0.001** 0.369
vRR (brpm) 4.57 3.39–6.34 4.45 3.33–6.49 0.11 0.913 0.761
mtI (sec) 1.13 0.96–1.26 0.83 0.80–0.99 5.44 <0.001** 0.569
vtI (sec) 0.22 0.16–0.36 0.13 0.09–0.21 3.99 <0.001** 0.476
mtE (sec) 1.48 1.33–1.73 1.14 0.98–1.41 4.10 <0.001** 0.888
vtE (sec) 0.43 0.30–0.55 0.23 0.17–0.32 4.87 <0.001** 0.385
mtTot (sec) 2.60 2.36–3.00 2.00 1.84–2.41 4.74 <0.001** 0.727
vtTot (sec) 0.53 0.41–0.72 0.33 0.26–0.37 4.86 <0.001** 1.000
mtI/tE 0.73 0.68–0.81 0.70 0.64–0.79 1.20 0.229 0.653
vtI/tE 0.23 0.18–0.30 0.16 0.13–0.21 3.55 <0.001** 0.397
mtI/tTot 0.42 0.40–0.44 0.41 0.39–0.44 1.20 0.229 0.652
vtI/tTot 0.07 0.06–0.09 0.05 0.04–0.07 3.37 0.001* 0.248
Flow-based parameters
mtPTEFSLP/tE 0.34 0.28–0.39 0.38 0.29–0.47 1.76 0.079 0.987
vtPTEFSLP/tE 0.22 0.16–0.26 0.21 0.13–0.33 0.14 0.885 0.102
mtPTIFSLP/tI 0.55 0.50–0.60 0.53 0.50–0.56 1.18 0.236 0.248
vtPTIFSLP/tI 0.21 0.18–0.27 0.16 0.13–0.19 4.65 <0.001** 0.113
mIE50SLP 1.31 1.20–1.50 1.47 1.33–1.73 3.13 0.002* 0.335
vIE50SLP 0.60 0.49–0.82 0.56 0.39–0.80 1.01 0.313 0.130
Regional parameters (relative contribution and asynchrony)
mrCT (%) 41.01 33.97–48.45 42.86 33.96–54.65 0.77 0.439 0.876
vrCT (%) 9.22 6.17–13.00 10.13 6.54–13.94 0.60 0.551 0.271
mHTA () 3.43 2.63–4.72 5.53 4.18–9.97 4.47 <0.001** 0.566
vHTA () 4.58 3.68–5.87 6.82 5.04–9.71 3.64 <0.001** 0.550
mTAA () 11.88 7.23–17.07 40.16 19.12–62.67 5.41 <0.001** <0.001**
vTAA () 13.53 8.80–21.77 24.08 16.57–31.28 4.21 <0.001** 0.170
Number of breaths 81 65–92 103 84.5–120 4.11 <0.001** 0.269
Median values (denoted by “m”) for all tidal breathing parameters were calculated for each participant, in addition to its IQR as a measure of
the within-subject variability (denoted by “v”). Individual data for all participants in each cohort were then combined and are summarized in
the table by their median and IQR.
ANOVA, analysis of variance; brpm, breaths per minute; HTA, left–right hemi-thoracic asynchrony; IE50SLP, SLP-derived tidal inspiratory flow at
50% of inspiratory volume divided by tidal expiratory flow at 50% of expiratory volume; IQR, interquartile range; MWU, Mann–Whitney U;
rCT, relative contribution of the thorax to each breath; RR, respiratory rate; SLP, structured light plethysmography; TAA, thoraco–abdominal
asynchrony; tE, expiratory time; tI, inspiratory time; tPTEFSLP, SLP-derived time to reach peak tidal expiratory flow; tPTIFSLP, SLP-derived time to
reach peak tidal inspiratory flow; tTot, total breath time.
aA robust ANOVA was used to determine whether differences in effect of asthma/wheeze on tidal breathing parameters differed between
younger (aged 2–5 years) and older (aged 6–12 years) children.
*Significant with P < 0.01.
**Significant with P < 0.001. All tests of overall significance had 69 degrees of freedom.
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Discussion
We compared SLP-assessed tidal breathing parameters in
children aged 2–12 years who were recovering from an
acute exacerbation of asthma/wheeze and had received
bronchodilator intervention in the course of their treat-
ment with those of healthy children of the same age. We
also carried out a secondary analysis to examine whether
the effect of asthma/wheeze or the effect of administration
of a bronchodilator differed between younger (aged 2–
5 years) and older (aged 6–12 years) children. In the
overall cohort, median values of seven parameters, and
the within-subject variability of eight parameters, were
identified that differed between children with and without
acute asthma/wheeze. After a further bronchodilator
administration, no change was observed in the median
value of any parameter; however, a reduction was
observed in the within-subject variability of one flow-
Figure 3. Two of the nine timing-based parameters (mtI [A], vtI [B]), and three flow-based parameters (vtPTEFSLP/tE [C], vtPTIFSLP/tI [D], and
mIE50SLP [E]) differed between healthy children (n = 54) and those with asthma/wheeze (n = 39) both pre- and post-bronchodilator
administration. The reduction in vtPTEFSLP/tE in the children with asthma following bronchodilator administration is also illustrated (C). The gray
line indicates the median value, the rectangle spans the interquartile range, and the black whiskers indicate the minimum and maximum values
(excluding the outliers indicated by the black circles). BD, bronchodilator; IE50SLP,SLP-derived tidal inspiratory flow at 50% of inspiratory volume
divided by tidal expiratory flow at 50% of expiratory volume; m, median; SLP, structured light plethysmography; tE, expiratory time; tI,
inspiratory time; tPTEFSLP, SLP-derived time to reach peak tidal expiratory flow; tPTIFSLP, SLP-derived time to reach peak tidal inspiratory flow; v,
within-subject variability.
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based parameter. We did, however, observe that the
response to both asthma/wheeze and to bronchodilation
differed between younger and older children, with greater
changes seen in regional parameters (TAA and rCT) in
younger children.
In the overall cohort, median IE50SLP was higher in
children with acute asthma/wheeze than those in the
healthy group. The conventional tidal breathing parame-
ter IE50 is defined as the ratio of inspiratory to expiratory
flow at 50% of tidal volume (Stick 1996). Studies have
demonstrated a reduction in TEF50 in obstructive airway
disorders including asthma (Totapally et al. 1996; Papiris
et al. 2002; Tauber et al. 2003). A reduction in TEF50,
without a reduction in TIF50, would increase IE50 and
explain the higher median IE50SLP observed in our study.
Elevated IE50 has been reported in other populations,
including in our previous studies in children aged 7–
16 years with nonacute asthma (Hmeidi et al. 2017) and
adults with COPD (Motamedi-Fakhr et al. 2017b).
IE50SLP did not respond to the additional bronchodilator
treatment administered to children with acute asthma/
wheeze during this study and remained higher than nor-
mal despite the children being in the recovery phase of
their illness and considered clinically stable. This is in
contrast to our findings in children with nonacute asthma
where a significant decrease in IE50SLP was observed fol-
lowing bronchodilator administration (Hmeidi et al.
2017). In this previous study, it was known that the chil-
dren had a lower forced expiratory volume in 1 sec
(FEV1) prior to the bronchodilator intervention and that
the reduction in IE50SLP following bronchodilator
Figure 4. The asynchrony-based parameters mTAA (A), vTAA (B), mHTA (C), and vHTA (D) differed in healthy children (n = 54) compared with
those with asthma/wheeze (n = 39) and remained so after bronchodilator administration. The gray line indicates the median value, the
rectangle spans the interquartile range, and the black whiskers indicate the minimum and maximum values (excluding the outliers indicated by
the black circles). BD, bronchodilator; HTA, left–right hemi-thoracic asynchrony; m, median; SLP, structured light plethysmography; TAA,
thoraco–abdominal asynchrony; v, within-subject variability.
Figure 5. mTAA in healthy children and those with asthma/
wheeze, stratified by age group. Error bars indicate the 25th and
75th quartiles. m, median; TAA, thoraco–abdominal asynchrony.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
2018 | Vol. 6 | Iss. 12 | e13752
Page 7
H. Hmeidi et al. SLP in Children with Acute Asthma/Wheeze
treatment was associated with an increase in % predicted
FEV1, indicating a bronchodilator response. In the present
study, however, it was unknown whether FEV1 was low
before bronchodilator intervention as spirometry was not
performed. Therefore, it may be possible that the
increased IE50SLP observed was indicative of the compo-
nent of airflow obstruction that is insensitive to
bronchodilator, or that there was simply no bronchodila-
tor response to observe. It is of note that in the previous
study in children with nonacute asthma, IE50SLP
remained significantly higher than normal after bron-
chodilation (Hmeidi et al. 2017). Our observations in the
present study may suggest that, although considered in
the recovery phase, these children were still experiencing
Table 3. SLP-assessed tidal breathing parameters in children with acute asthma/wheeze before and after bronchodilator administration. Sig-
nificantly different parameters are shown in bold italics.
Children with acute
asthma/wheeze (before
bronchodilator)
(N = 39)
Children with acute
asthma/wheeze (after
bronchodilator)
(N = 39)
Overall significance
(WSR test)
Age group interaction
significancea
(MWU test)
Median IQR Median IQR z-statistic P-value P-value
Timing indices and ratios
mRR (brpm) 30.00 24.87–32.58 31.03 25.08–33.33 1.56 0.118 0.305
vRR (brpm) 4.45 3.33–6.49 4.36 3.73–6.58 0.47 0.635 0.146
mtI (sec) 0.83 0.80–0.99 0.80 0.74–0.95 1.61 0.108 0.612
vtI (sec) 0.13 0.09–0.21 0.13 0.09–0.20 0.50 0.619 0.828
mtE (sec) 1.14 0.98–1.41 1.13 1.00–1.40 1.06 0.290 0.175
vtE (sec) 0.23 0.17–0.32 0.25 0.19–0.34 0.82 0.410 0.603
mtTot (sec) 2.00 1.84–2.41 1.93 1.80–2.39 1.61 0.107 0.363
vtTot (sec) 0.33 0.26–0.37 0.32 0.23–0.43 0.30 0.763 0.419
mtI/tE 0.70 0.64–0.79 0.70 0.62–0.76 1.03 0.301 0.665
vtI/tE 0.16 0.13–0.21 0.14 0.13–0.19 1.35 0.176 0.283
mtI/tTot 0.41 0.39–0.44 0.41 0.38–0.43 0.97 0.331 0.707
vtI/tTot 0.05 0.04–0.07 0.05 0.04–0.06 1.31 0.190 0.246
Flow-based parameters
mtPTEFSLP/tE 0.38 0.29–0.47 0.37 0.31–0.45 0.85 0.395 0.679
vtPTEFSLP/tE 0.21 0.13–0.33 0.15 0.11–0.23 3.87 <0.001** 0.352
mtPTIFSLP/tI 0.53 0.50–0.56 0.53 0.50–0.56 1.24 0.213 0.564
vtPTIFSLP/tI 0.16 0.13–0.19 0.17 0.12–0.20 0.10 0.922 0.658
mIE50SLP 1.47 1.33–1.73 1.50 1.35–1.67 0.71 0.477 0.598
vIE50SLP 0.56 0.39–0.80 0.52 0.37–0.74 1.84 0.065 0.309
Regional parameters (relative contribution and phase)
mrCT (%) 42.86 33.96–54.65 39.47 31.34–51.19 1.95 0.051 0.041*
vrCT (%) 10.13 6.54–13.94 8.98 6.48–11.06 1.45 0.147 0.051
mHTA () 5.53 4.18–9.97 5.98 4.18–9.51 0.82 0.41 0.338
vHTA () 6.82 5.04–9.71 6.82 4.84–9.93 0.03 0.978 0.449
mTAA () 40.16 19.12–62.67 31.08 18.63–57.89 0.89 0.372 0.030*
vTAA () 24.08 16.57–31.28 20.31 14.14–28.71 1.41 0.159 0.020*
Number of breaths 103 84.5–120 107 93–115.8 1.68 0.094 0.862
Median values (denoted by “m”) for all tidal breathing parameters were calculated for each participant, in addition to its IQR as a measure of
the within-subject variability (denoted by “v”). Individual data for all participants in each cohort were then combined and are summarized in
the table by their median and IQR.
brpm, breaths per minute; HTA, left–right hemi-thoracic asynchrony; IE50SLP, SLP-derived tidal inspiratory flow at 50% of inspiratory volume
divided by tidal expiratory flow at 50% of expiratory volume; IQR, interquartile range; MWU, Mann–Whitney U; rCT, relative contribution of
the thorax to each breath; RR, respiratory rate; SLP, structured light plethysmography; TAA, thoraco–abdominal asynchrony; tE, expiratory
time; tI, inspiratory time; tPTEFSLP, SLP-derived time to reach peak tidal expiratory flow; tPTIFSLP, SLP-derived time to reach peak tidal inspira-
tory flow; tTot, total breath time; WSR, Wilcoxon signed-rank.
aA MWU test of the differences before and after bronchodilator was used to determine whether the effects of bronchodilator on tidal breath-
ing parameters differed between younger (aged 2–5 years) and older (aged 6–12 years) children.
*Significant with P < 0.05.
**Significant with P < 0.001. All tests of overall significance had 69 degrees of freedom.
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the effects of respiratory exacerbation. In other studies,
bronchodilator treatment in patients with asthma was fol-
lowed by a return of traditional tidal breathing parame-
ters toward normal (Kuratomi et al. 1985; van der Ent
et al. 1996). It would be of interest to directly compare
IE50SLP in the same asthmatic children with and without
an exacerbation and throughout recovery from an exacer-
bation in order to determine whether this variable could
be used to monitor disease activity.
Both asynchrony parameters (TAA and HTA) were sig-
nificantly greater in children with acute asthma/wheeze
compared with healthy controls, as was their within-sub-
ject variability. Although some asynchrony can be
detected in healthy children (Sivan et al. 1990; Newth and
Hammer 2005), generally the thorax and abdomen move
in phase in those without obstructive disease. However,
when the work of breathing increases in children with
acute asthma, movement of the abdomen precedes that of
the thorax, resulting in a loss of this synchrony (Carlsen
and Lodrup Carlsen 2010; Giordano et al. 2012). The
observation that within-subject variability in asynchrony
is greater in children with asthma both between the tho-
rax and abdomen and between the left and right hemi-
thorax may suggest a compensatory mechanism in which
spatial variability is introduced into the system when tem-
poral variability is reduced. Within-subject variability of
asynchrony was not previously observed in children with
nonacute asthma when compared with healthy subjects
(Hmeidi et al. 2017); however, the children in that study
were older so were likely to have reduced chest wall com-
pliance, and thus, less propensity for regional variation.
This effect of age is further supported by our observation
in the current study that the effect of asthma/wheeze on
TAA was greater in younger children than in the older
cohort. To our knowledge, the effects of acute asthma on
HTA (or on variability in asynchrony parameters) have
not been reported before.
In contrast to the increased within-subject variability
observed in asynchrony parameters, variability of
tPTIFSLP/tI was lower than normal in the acute asthma
group. This was not as we had expected as it has previ-
ously been reported that children with asthma have
greater variability in, for example, airway resistance (Lall
et al. 2007). Our observation may have been attributable
to the repeated bronchodilator treatment received by our
patient group prior to the test intervention. The variabil-
ity in tPTEFSLP/tE reduced in response to bronchodilator
treatment, which is in accordance with that reported for
the variation in airways resistance in both asthmatics and
controls following administration of a bronchodilator
(Lall et al. 2007). Similarly, in our previous study in chil-
dren with nonacute asthma, we detected a nonsignificant
Figure 6. Change in (A) mrCT, (B) mTAA, and (C) vTAA after treatment with bronchodilator in children with asthma/wheeze, stratified by age
group. Error bars indicate the 25th and 75th quartiles. m, median; rCT, relative contribution of the thorax; TAA, thoraco–abdominal
asynchrony; v, within-subject variability.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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reduction in the variation of tPTEFSLP/tE in response to
bronchodilator intervention, and the difference observed
between healthy and asthmatics pre-bronchodilator was
no longer apparent post-bronchodilator, suggesting that
some reduction had occurred (Hmeidi et al. 2017). No
such reduction was observed in the variability of IE50SLP
in response to bronchodilator treatment in our group of
patients recovering from an acute exacerbation. In the
study by Lall et al. (2007), it was reported that reduction
in variability in airways resistance exceeded that of FEV1.
Our observations may suggest that the variability of
tPTEF/tE may, similarly, be more sensitive to the effects
of bronchodilator intervention than the variability of
IE50. Further work will be required to investigate this.
Compared with older children, administration of bron-
chodilator had a greater effect on mTAA and vTAA in
younger children, who exhibited reduced and less variable
asynchrony. Furthermore, their breathing also became
more abdominal as indicated by reduced mrCT. These
observations had not been apparent in our previous study
of older children, so we suggest that it is a characteristic
effect in younger children due to differences in chest wall
compliance.
In the present study, RR was higher in acute asthma/
wheeze and the duration of the respiratory cycle as a whole
(i.e., tTot) and its components (tI and tE) were shorter
compared with those of healthy children. Patients with
acute asthma have a higher RR than normal to compensate
Table 4. SLP-assessed tidal breathing parametersa in children with acute asthma/wheeze (after bronchodilator administration) versus healthy
children. Significantly different parameters are shown in bold italics.
Healthy children
(N = 54)
Children with acute
asthma/wheeze (after
bronchodilator)
(N = 39)
Overall significance
(MWU test)
Age group interaction
significanceb
(robust ANOVA)
Median IQR Median IQR z-statistic P-value P-value
Timing indices and ratios
mRR (brpm) 23.00 20.00–25.35 31.03 25.08–33.33 5.01 <0.001** 0.642
mtI (sec) 1.13 0.96 –1.26 0.8 0.74–0.95 5.67 <0.001** 1.000
vtI (sec) 0.22 0.16–0.36 0.13 0.09–0.20 4.57 <0.001** 0.782
mtE (sec) 1.48 1.33–1.73 1.13 1.00–1.40 4.17 <0.001** 0.814
vtE (sec) 0.43 0.30–0.55 0.25 0.19–0.34 4.72 <0.001** 0.195
mtTot (sec) 2.60 2.36–3.00 1.93 1.80–2.39 5.02 <0.001** 0.924
vtTot (sec) 0.53 0.41–0.72 0.32 0.23–0.43 4.66 <0.001** 0.508
vtI/tE 0.23 0.18–0.30 0.14 0.13–0.19 4.18 <0.001** 0.663
vtI/tTot 0.07 0.06–0.09 0.05 0.04–0.06 4.09 <0.001** 0.321
Flow-based parameters
vtPTIFSLP/tI 0.21 0.18–0.27 0.17 0.12–0.20 4.26 <0.001** 0.083
mIE50SLP 1.31 1.20–1.50 1.50 1.35–1.67 3.26 0.001* 0.350
Regional parameters (relative contribution and phase)
mHTA () 3.43 2.63–4.72 5.98 4.18–9.51 4.11 <0.001** 0.796
vHTA () 4.58 3.68–5.87 6.82 4.84–9.93 3.29 0.001* 0.767
mTAA () 11.88 7.23–17.07 31.08 18.63–57.89 5.21 <0.001** 0.054
vTAA () 13.53 8.80–21.77 20.31 14.14–28.71 3.34 0.001* 0.682
Number of breaths 81 65–92 107 93–115.8 5.33 <0.001** 0.271
Median values (denoted by “m”) for all tidal breathing parameters were calculated for each participant, in addition to its IQR as a measure of
the within-subject variability (denoted by “v”). Individual data for all participants in each cohort were then combined and are summarized in
the table by their median and IQR.
ANOVA, analysis of variance; brpm, breaths per minute; HTA, left–right hemi-thoracic asynchrony; IE50SLP, SLP-derived tidal inspiratory flow at
50% of inspiratory volume divided by tidal expiratory flow at 50% of expiratory volume; IQR, interquartile range; MWU, Mann–Whitney U;
RR, respiratory rate; SLP, structured light plethysmography; TAA, thoraco–abdominal asynchrony; tE, expiratory time; tI, inspiratory time;
tPTIFSLP, SLP-derived time to reach peak tidal inspiratory flow; tTot, total breath time.
aData are shown only for those parameters that differed between children with asthma (before bronchodilator administration) and healthy
children (see Table 2).
bA robust ANOVA was used to determine whether differences in effect of asthma/wheeze on tidal breathing parameters differed between
younger (aged 2–5 years) and older (aged 6–12 years) children.
*Significant with P < 0.01.
**Significant with P < 0.001. All tests of overall significance had 69 degrees of freedom.
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for the reduced amount of air inhaled at each breath as a
result of airway obstruction (Kesten et al. 1990). With the
exception of RR, all timing indices and ratios showed
reduced within-subject variability in children with acute
asthma/wheeze. This decrease was expected as the RR was
faster in these children, allowing less freedom for variation.
As observed in our study, healthy subjects typically display
some variability in tidal breathing parameters (Tobin et al.
1988). The propensity for normal breathing patterns to
vary allows the respiratory system to participate in tasks
besides gas exchange, such as speech and coughing (Brack
et al. 2002). SLP is well placed to assess within-subject vari-
ability as it involves the measurement of a large number of
consecutive breaths (mean ≥80 breaths per assessment in
the current study).
SLP is a noncontact technique that does not require
equipment such as facemasks that may inadvertently
influence tidal breathing, and requires only minimal
Table 5. CLES evaluation of SLP-obtained breathing parameters.
Hypothesis CLES (%) Interpretation
Healthy vs. children with asthmaa (before BD administration)
mRR: higher in asthma group 78.5 In 78.5% of cases, mRR was higher in asthma group
mtI: lower in asthma group 82.1 In 82.1% of cases, mtI was lower in asthma group
vtI: lower in asthma group 73.2 In 73.2% of cases, vtI was lower in asthma group
mtE: lower in asthma group 74.2 In 74.2% of cases, mtE was lower in asthma group
vtE: lower in asthma group 79.2 In 79.2% of cases, vtE was lower in asthma group
mtTot: lower in asthma group 78.5 In 78.5% of cases, mtTot was lower in asthma group
vtTot: lower in asthma group 79.1 In 79.1% of cases, vtTot was lower in asthma group
vtI/tE: lower in asthma group 71.7 In 71.7% of cases, vtI/tE was lower in asthma group
vtI/tTot: lower in asthma group 70.6 In 70.6% of cases, vtI/tTot was lower in asthma group
vtPTIFSLP/tI: lower in asthma group 78.4 In 78.4% of cases, vtPTIFSLP/tI was lower in asthma group
mIE50SLP: higher in asthma group 69.1 In 69.1% of cases, mIE50SLP was higher in asthma group
mHTA: higher in asthma group 77.3 In 77.3% of cases, mHTA was higher in asthma group
vHTA: higher in asthma group 72.2 In 72.2% of cases, vHTA was higher in asthma group
mTAA: higher in asthma group 83.0 In 83.0% of cases, mTAA was higher in asthma group
vTAA: higher in asthma group 75.7 In 75.7% of cases, vTAA was higher in asthma group
Healthy vs. children with asthmaa (after BD administration)
mRR: higher in asthma group 80.2 In 80.2% of cases, mRR was higher in asthma group
mtI: lower in asthma group 83.4 In 83.4% of cases, mtI was lower in asthma group
vtI: lower in asthma group 76.5 In 76.5% of cases, vtI was lower in asthma group
mtE: lower in asthma group 74.9 In 74.9% of cases, mtE was lower in asthma group
vtE: lower in asthma group 78.1 In 78.1% of cases, vtE was lower in asthma group
mtTot: lower in asthma group 80.2 In 80.2% of cases, mtTot was lower in asthma group
vtTot: lower in asthma group 77.9 In 77.9% of cases, vtTot was lower in asthma group
vtI/tE: lower in asthma group 75.5 In 75.5% of cases, vtI/tE was lower in asthma group
vtI/tTot: lower in asthma group 75.0 In 75.0% of cases, vtI/tTot was lower in asthma group
vtPTEFSLP/tE: lower in asthma group 64.9 In 64.9% of cases, vtPTEFSLP/tE was lower in asthma group
vtPTIFSLP/tI: lower in asthma group 76.0 In 76.0% of cases, vtPTIFSLP/tI was lower in asthma group
mIE50SLP: higher in asthma group 69.9 In 69.9% of cases, mIE50SLP was higher in asthma group
mHTA: higher in asthma group 75.1 In 75.1% of cases, mHTA was higher in asthma group
vHTA: higher in asthma group 70.1 In 70.1% of cases, vHTA was higher in asthma group
mTAA: higher in asthma group 81.8 In 81.8% of cases, mTAA was higher in asthma group
vTAA: higher in asthma group 70.4 In 70.4% of cases, vTAA was higher in asthma group
Before vs. after BD administrationb (children with asthma)
vtPTEFSLP/tE: reduced after BD 74.4 In 74.4% of cases, vtPTEFSLP/tE decreased after BD
Median and interquartile range values for each parameter are denoted by the prefix “m” and “v”, respectively.
BD, bronchodilator; CLES, common language effect size; HTA, left–right hemi-thoracic asynchrony; IE50SLP, SLP-derived tidal inspiratory flow
at 50% of inspiratory volume divided by expiratory flow at 50% of expiratory volume; RR, respiratory rate; SLP, structured light plethysmogra-
phy; TAA, thoraco–abdominal asynchrony; tE, expiratory time; tI, inspiratory time; tPTEFSLP, SLP-derived time to reach peak tidal expiratory
flow; tPTIFSLP, SLP-derived time to reach peak tidal inspiratory flow; tTot, total breath time.
aData are shown for parameters that significantly differed between healthy children and children with asthma (pre- and post-bronchodilator
administration) only (see Tables 2 and 4).
bData are shown for parameters that significantly differed following BD administration in children with asthma only (see Table 3).
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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cooperation from the subject. One limitation of the
method is that it requires individuals to stay still for sev-
eral minutes. Consequently, we did not attempt to assess
children with asthma who presented with an acute exacer-
bation until they were in the recovery phase of the illness
and considered clinically stable. It is likely, therefore, that
the study missed changes in tidal breathing parameters
occurring during the exacerbation. Furthermore, assess-
ment of the SLP response to bronchodilators was con-
founded by the previous bronchodilator treatments
received since admission and prior to enrollment.
As multiple comparisons were made during this study,
the risk of some statistically significant results occurring
by chance should be considered. The Bonferroni correc-
tion was not applied as this method assumes that all
comparisons are independent, which was not the case
here. Initial statistical comparisons were supported by
CLES evaluation, and many of the observed changes in
SLP parameters appear to have a firm physiological basis
or are corroborated by other studies (Laveneziana et al.
2015b; Motamedi-Fakhr et al. 2017b).
Here, we have shown that SLP can be performed suc-
cessfully in children as young as 2 years of age recovering
from acute asthma/wheeze. In addition, certain SLP
parameters, in particular IE50SLP, RR and asynchrony
(both hemi-thoracic and thoraco–abdominal), along with
the within-subject variability of multiple parameters, dif-
fered in the acute asthma group, and so may offer the
clinician a means of distinguishing between these children
and their healthy counterparts, and also a means of moni-
toring recovery. SLP may prove particularly useful in the
preschool age group where providing an accurate asthma
diagnosis is a major clinical challenge due to the difficul-
ties in assessing airflow limitation at this age. These pre-
liminary results look promising and support further study
and refinement of the technique and data analysis meth-
ods with an aim toward introduction into routine clinical
practice. Further study is also necessary to evaluate the
effects of age on breathing patterns; SLP may represent a
method for assessing lung function in patient populations
in whom traditional techniques such as spirometry cannot
be conveniently used.
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